Dear Colleagues and Friends,

The biannual MMND (former MMD) - IPCT workshops, founded in collaboration with Memorial Sloan Kettering Cancer Center (MSKCC) in 2001, has become an important international multidisciplinary forum for the discussion of advanced QA dosimetry technology for radiation therapy and space science, as well as advanced technologies for prostate cancer treatment. The last MMND IPCT, held in Port Douglas in 2014, was a great success due to the very interesting scientific and social programs and an outstanding international faculty. The workshops were attended by more than 150 medical physicists, radiation oncologists, radiation detector experts, radiobiologists and radiation space scientists.

In more recent years, the interests of participants and the scope of the workshops have extended far beyond prostate cancer treatment alone to include all aspects of radiation therapy, radiation science and technology. We therefore decided to change the name for 2016 to Innovative Technologies in Radiation Oncology (ITRO).

The MMND program will continue to cover advanced medical physics aspects of IMRT, IGRT, VMAT, SBRT, MRI LINAC, innovative brachytherapy, and synchrotron MRT. The demand for sophisticated real time and high temporal and spatial resolution (down to the micron level) dosimetry methods and instrumentation for end–to-end QA for these radiotherapy technologies is increasing. Special attention will be paid to the contribution of advanced imaging and the application of nanoscience to the recent improvements in imaging and radiotherapy.

The last decade has seen great progress in charged particle therapy technology which has spread throughout the world and attracted strong current interest in Australia. This demands a better understanding of the fundamental aspects of ion interactions with biological tissue and the RBE of protons and heavy ions. The further development of computational and experimental micro–and nano-dosimetry for ions has important application in radiobiology based treatment planning and space radiation hazard prediction. New compact accelerator technologies for the delivery of proton and heavy ion therapy and relevant QA dosimetry instrumentation are a focus of MMND.

The ITRO program this year is dedicated to clinical aspects of innovative SBRT for cancer treatment. It will represent a unique opportunity to learn from didactic lectures as well as case based discussions with world leaders in the field in the relaxed atmosphere of Hobart.

As well as the outstanding scientific program, MMND ITRO 2016 includes an Australian beach BBQ to celebrate Australia Day on the evening of 26th January and an exciting social program on 29th January followed by the conference dinner and great Australian hospitality.

We wish you a productive and pleasant time during MMND ITRO 2016 at the beautiful Wrest Point Hotel in Hobart and we are sure both workshops will be the next step in improving cancer treatment with radiation.

Dr. Josh Yamada, MD
Professor Anatoly Rozenfeld, PhD
General Chair MMND ITRO
CMRP, University of Wollongong